Bao Z - Search Results

1

Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drug.

Jung S, Bufton J, Bao Z, Cho W, Aguiar D, Allen C. Jung S, et al. Among authors: bao z. Data Brief. 2024 Dec 4;58:111182. doi: 10.1016/j.dib.2024.111182. eCollection 2025 Feb. Data Brief. 2024. PMID: 39802831 Free PMC article.

2

Data evaluating triamcinolone acetonide and triamcinolone hexacetonide loaded poly(δ-valerolactone-co-allyl-δ-valerolactone) microparticles.

Bao Z, Jung S, Bufton J, Bannigan P, Aguiar DJ, Allen C. Bao Z, et al. Data Brief. 2023 Mar 1;48:109032. doi: 10.1016/j.dib.2023.109032. eCollection 2023 Jun. Data Brief. 2023. PMID: 36950558 Free PMC article.

3

Poly(δ-valerolactone-co-allyl-δ-valerolactone) cross-linked microparticles: Formulation, characterization and biocompatibility.

Bao Z, Jung S, Bufton J, Evans JC, Aguiar DJ, Allen C. Bao Z, et al. J Pharm Sci. 2021 Jul;110(7):2771-2777. doi: 10.1016/j.xphs.2021.03.009. Epub 2021 Mar 16. J Pharm Sci. 2021. PMID: 33737020

4

Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel.

Bufton J, Jung S, Evans JC, Bao Z, Aguiar D, Allen C. Bufton J, et al. Among authors: bao z. Eur J Pharm Sci. 2021 Jul 1;162:105808. doi: 10.1016/j.ejps.2021.105808. Epub 2021 Mar 15. Eur J Pharm Sci. 2021. PMID: 33737226

5

Revolutionizing drug formulation development: The increasing impact of machine learning.

Bao Z, Bufton J, Hickman RJ, Aspuru-Guzik A, Bannigan P, Allen C. Bao Z, et al. Adv Drug Deliv Rev. 2023 Nov;202:115108. doi: 10.1016/j.addr.2023.115108. Epub 2023 Sep 27. Adv Drug Deliv Rev. 2023. PMID: 37774977 Review.

6

Machine learning models to accelerate the design of polymeric long-acting injectables.

Bannigan P, Bao Z, Hickman RJ, Aldeghi M, Häse F, Aspuru-Guzik A, Allen C. Bannigan P, et al. Among authors: bao z. Nat Commun. 2023 Jan 10;14(1):35. doi: 10.1038/s41467-022-35343-w. Nat Commun. 2023. PMID: 36627280 Free PMC article.

7

Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug.

Bao Z, Yung F, Hickman RJ, Aspuru-Guzik A, Bannigan P, Allen C. Bao Z, et al. Drug Deliv Transl Res. 2024 Jul;14(7):1872-1887. doi: 10.1007/s13346-023-01491-9. Epub 2023 Dec 29. Drug Deliv Transl Res. 2024. PMID: 38158474

8

Machine learning directed drug formulation development.

Bannigan P, Aldeghi M, Bao Z, Häse F, Aspuru-Guzik A, Allen C. Bannigan P, et al. Among authors: bao z. Adv Drug Deliv Rev. 2021 Aug;175:113806. doi: 10.1016/j.addr.2021.05.016. Epub 2021 May 19. Adv Drug Deliv Rev. 2021. PMID: 34019959 Review.

9

Self-driving laboratories: A paradigm shift in nanomedicine development.

Hickman RJ, Bannigan P, Bao Z, Aspuru-Guzik A, Allen C. Hickman RJ, et al. Among authors: bao z. Matter. 2023 Apr 5;6(4):1071-1081. doi: 10.1016/j.matt.2023.02.007. Epub 2023 Mar 8. Matter. 2023. PMID: 37020832 Free PMC article. Review.

10

Towards the prediction of drug solubility in binary solvent mixtures at various temperatures using machine learning.

Bao Z, Tom G, Cheng A, Watchorn J, Aspuru-Guzik A, Allen C. Bao Z, et al. J Cheminform. 2024 Oct 28;16(1):117. doi: 10.1186/s13321-024-00911-3. J Cheminform. 2024. PMID: 39468626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,685 results

Search Page

Filters